KR860001787A - 신규 δ-부티로락탐의 제조 방법 - Google Patents
신규 δ-부티로락탐의 제조 방법 Download PDFInfo
- Publication number
- KR860001787A KR860001787A KR1019850006078A KR850006078A KR860001787A KR 860001787 A KR860001787 A KR 860001787A KR 1019850006078 A KR1019850006078 A KR 1019850006078A KR 850006078 A KR850006078 A KR 850006078A KR 860001787 A KR860001787 A KR 860001787A
- Authority
- KR
- South Korea
- Prior art keywords
- group
- carbon atoms
- compound
- hydrogen
- chemical bond
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Joining Of Building Structures In Genera (AREA)
- Package Frames And Binding Bands (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyrrole Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (15)
- 다음 구조식의 화합물.위 식에서, R는 1 내지 10개의 탄소 원자를 알킬기, 아릴기 또는 아랄킬기이고, R1은 수소, 1 내지 10개의 탄소 원자를 갖는 알킬기, 아릴기 또는 아랄킬기, 1 내지 18개의 탄소 원자를 갖는 아실기, 또는 R3와 함께 하나의 화학 결합을 나타내며, R2는 수소이거나, 또는 R3와 함께 산소를 나타내고 R3는 수소, 히드록시, 1 내지 10개의 탄소 원자를 갖는 알콕시기, 아릴옥시기 또는 아랄킬옥시기, 1 내지 18개의 탄소 원자를 갖는 아실옥시, R1또는 R4와 함께 하나의 화학 결합을 나타내거나, 또는 R2와 함께 산소를 나타내며, R4는 수소, R3와 함께 화학 결합을 나타내거나, 또는 R5의 정의와 같고, R5및 R6은 동일하거나 또는 상이한 것으로서, 수소, 1 내지 10개의 탄소 원자를 갖는 알킬기, 아릴기 또는 아랄킬기, 1 내지 10개의 탄소 원자를 갖는 알콕시기, 아릴옥시기 또는 아랄콕시기, 1 내지 18개의 탄소 원자를 갖는 아실기, CF3OCF3, 니트로, 히드록시, 할로겐, 아미노, 알킬기 중에 1 내지 14개의 탄소 원자를 갖는 디알킬아미노, 카르복시, SO3H 또는 1 내지 18개의 탄소원자를 갖는 아실아미노이다.
- 제1항에 있어서, 알킬기 및 알콕시기가 각각 1 내지 6개의 탄소 원자를 갖는 것, 적합하기로는 각각 메틸기 또는 메톡시기임을 특징으로 하는 화합물.
- 제1 또는 2항에 있어서, 아실기가 1 내지 4개의 탄소 원자를 갖는 것, 적합하기로는 아세틸기임을 특징으로 하는 화합물.
- 제1 내지 3항에 있어서, 아릴기, 아랄킬기, 아릴옥시기 및 아랄킬옥시기가 각각 페닐, 벤질, 페녹시 및 벤질옥시기임을 특징으로 하는 화합물.
- 제1 내지 4항 중 임의의 항에 있어서, R는 메틸기이고 R1은 수소, 알킬기, 아실기 또는 R3와 함께 화학 결합을 나타내며, R2는 수소이고, R3은 히드록시, 알킬옥시, 아실옥시 또는 R1또는 R4와 함께 화학결합을 나타내고, R5및 R6은 수소인 화합물.
- 다음 구조식의 입체 이성질체.
- 다음 구조식의 클라우젠아미드.
- 다음 구조식의 화합물.
- 다음 구조식의 화합물.
- (a) 클라우제나 란슘의 잎을 끓는 물로 처리하는 공정, (b) 농축시킨 수용성 추출액을 흡착제, 적합하기로는 실리카겔과 혼합시키는 공정, (c) 흡착물을 유기 용매, 적합하기로는 클로로포름으로 추출시키는 공정, (d) 유기 용출물을 농축시키는 공정, (e) 농축물을 냉 C1-C6알코올 또는 C2-C6-케톤으로 세척하는 공정으로 이루어진 것이 특징인 클라우젠아미드의 단리 방법.
- (a) 클라우제나 란슘의 잎을 끓는 물로 처리하는 공정, (b) 농축시킨 수용성 추출액의 묽, 은산을 첨가하는 공정, (c) 상층액을 양이온 교환수지에 통과시키는 공정, (d) 수지를 염기, 적합하기로는 암모니아수로 처리하는 공정, (e) 수지를 유기 용매로 추출하는 공정, (f) 농축된 추출액을 용출제로서 클로로포름, 염화메틸렌, 에테르 또는 클로로포름/메탄을 혼합물을 사용하는 실리카 또는 산화 알루미늄으로 크로마토 그래피시키는 공정, (g) 화합물 (0) 또는 화합물(9) 각각에 대응하는 Rf-치를 갖는 용출물을 모아서 농축시키는 공정으로 이루어진 것이 특징인 화합물(0) 및 또는 화합물(9)의 단리 방법.
- 제1 내지 7항중 임의의 항에 의한 화합물을 유효 성분으로 함유하는 제약 조성물.
- 제1 내지 7항중 임의의 항에 의한 하합물을 희석제 및/또는 기타 첨가제 또는 보조제와 혼합시키는 것을 특징으로 하는 제10항 기재의 제약 조성물의 제조 방법.
- 급성 및 만성 바이러스성 간장염, 간 중독, 저산소증 또는 건망증의 치료에 사용하기 위한 제1 내지 7항에 기재의 화합물.
- 급성 및 만성 바이러스성 간장염, 간 중독, 저산소증 또는 건망증을 치료하기 위한 제1 내지 7항 기재의 화합물의 용도.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19843431257 DE3431257A1 (de) | 1984-08-24 | 1984-08-24 | Neue (delta)-butyrolactame, pharmakologisch aktive zusammensetzungen derselben, verfahren zu ihrer herstellung und ihre medizinische verwendung |
DEP3431257.9 | 1984-08-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR860001787A true KR860001787A (ko) | 1986-03-22 |
Family
ID=6243847
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019850006078A KR860001787A (ko) | 1984-08-24 | 1985-08-23 | 신규 δ-부티로락탐의 제조 방법 |
Country Status (16)
Country | Link |
---|---|
US (1) | US4879390A (ko) |
EP (1) | EP0172514B1 (ko) |
JP (1) | JPH0660159B2 (ko) |
KR (1) | KR860001787A (ko) |
AT (1) | ATE46504T1 (ko) |
AU (1) | AU571729B2 (ko) |
CA (1) | CA1262250A (ko) |
DE (2) | DE3431257A1 (ko) |
DK (1) | DK385285A (ko) |
ES (2) | ES8609241A1 (ko) |
FI (1) | FI853228L (ko) |
GR (1) | GR852050B (ko) |
HU (1) | HU195774B (ko) |
IL (1) | IL76157A (ko) |
PT (1) | PT81005B (ko) |
ZA (1) | ZA856414B (ko) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU579029B2 (en) * | 1985-10-18 | 1988-11-10 | Bayer Aktiengesellschaft | Process for the preparation of ` -butyrolactams |
DE3616989A1 (de) * | 1986-05-21 | 1987-11-26 | Bayer Ag | Enantiomerenreine 4,5-disubstituierte (gamma)-butyrolactame, verfahren zu ihrer herstellung und ihre verwendung |
DE3927370A1 (de) * | 1989-08-19 | 1991-02-21 | Bayer Ag | Verfahren zur herstellung von clausenamid und neoclausenamid und deren derivate |
DE3927367A1 (de) * | 1989-08-19 | 1991-02-21 | Bayer Ag | Verfahren zur herstellung von dehydrocycloclausenamid und dessen derivate in der racemischen form und als optisch aktive (+) oder (-)-enantiomere |
JP4585073B2 (ja) * | 2000-02-15 | 2010-11-24 | 丸善製薬株式会社 | 抗男性ホルモン剤、養毛化粧料、前立腺肥大抑制剤、外用剤及び飲食品 |
US6787564B2 (en) * | 2002-03-26 | 2004-09-07 | Institute Of Materia Medica, Chinese Academy Of Medical Sciences | Optically active clausenamides, process of the preparation thereof, pharmaceutical composition containing the same and their medical use |
EP1348696B1 (en) * | 2002-03-26 | 2012-02-01 | Institute Of Materia Medica, Chinese Academy Of Medical Sciences | Use of optically active clausenamides for the preparation of pharmaceutical compositions, pharmaceutical compositions containing the same |
CN1295215C (zh) * | 2002-12-31 | 2007-01-17 | 中国医学科学院药物研究所 | 黄皮酰胺的光学活性衍生物、其制法和其药物组合物与用途 |
WO2016015333A1 (en) * | 2014-08-01 | 2016-02-04 | F.Hoffmann-La Roche Ag | 2-oxa-5-azabicyclo [2.2.1] heptan-3-yl derivatives |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI325174A (ko) * | 1973-11-19 | 1975-05-20 | Sandoz Ag |
-
1984
- 1984-08-24 DE DE19843431257 patent/DE3431257A1/de not_active Withdrawn
-
1985
- 1985-08-12 DE DE8585110087T patent/DE3573113D1/de not_active Expired
- 1985-08-12 AT AT85110087T patent/ATE46504T1/de not_active IP Right Cessation
- 1985-08-12 EP EP85110087A patent/EP0172514B1/en not_active Expired
- 1985-08-21 IL IL76157A patent/IL76157A/xx unknown
- 1985-08-22 FI FI853228A patent/FI853228L/fi not_active Application Discontinuation
- 1985-08-22 JP JP60183161A patent/JPH0660159B2/ja not_active Expired - Lifetime
- 1985-08-22 AU AU46571/85A patent/AU571729B2/en not_active Ceased
- 1985-08-22 PT PT81005A patent/PT81005B/pt unknown
- 1985-08-22 CA CA000489253A patent/CA1262250A/en not_active Expired
- 1985-08-23 ES ES546381A patent/ES8609241A1/es not_active Expired
- 1985-08-23 HU HU853219A patent/HU195774B/hu not_active IP Right Cessation
- 1985-08-23 GR GR852050A patent/GR852050B/el unknown
- 1985-08-23 DK DK385285A patent/DK385285A/da not_active Application Discontinuation
- 1985-08-23 ZA ZA856414A patent/ZA856414B/xx unknown
- 1985-08-23 KR KR1019850006078A patent/KR860001787A/ko not_active IP Right Cessation
-
1986
- 1986-04-16 ES ES554061A patent/ES8704457A1/es not_active Expired
-
1988
- 1988-04-27 US US07/186,540 patent/US4879390A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DK385285A (da) | 1986-02-25 |
JPH0660159B2 (ja) | 1994-08-10 |
ES546381A0 (es) | 1986-07-16 |
EP0172514A1 (en) | 1986-02-26 |
PT81005A (en) | 1985-09-01 |
US4879390A (en) | 1989-11-07 |
PT81005B (en) | 1987-06-26 |
ES8704457A1 (es) | 1987-04-01 |
EP0172514B1 (en) | 1989-09-20 |
HUT38904A (en) | 1986-07-28 |
AU571729B2 (en) | 1988-04-21 |
GR852050B (ko) | 1985-12-20 |
ES8609241A1 (es) | 1986-07-16 |
IL76157A (en) | 1988-08-31 |
ES554061A0 (es) | 1987-04-01 |
HU195774B (en) | 1988-07-28 |
DK385285D0 (da) | 1985-08-23 |
FI853228A0 (fi) | 1985-08-22 |
ATE46504T1 (de) | 1989-10-15 |
ZA856414B (en) | 1986-04-30 |
DE3431257A1 (de) | 1986-03-06 |
FI853228L (fi) | 1986-02-25 |
CA1262250A (en) | 1989-10-10 |
AU4657185A (en) | 1986-02-27 |
DE3573113D1 (en) | 1989-10-26 |
IL76157A0 (en) | 1985-12-31 |
JPS62181250A (ja) | 1987-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yotsu et al. | The structure of chiriquitoxin from the Costa Rican frog Atelopus chiriquiensis | |
KR860001787A (ko) | 신규 δ-부티로락탐의 제조 방법 | |
DK299887A (da) | Fremgangsmaade til fremstilling af sterile pyrogenfrie farmaceutiske praeparater af ligeret radioaktivt rhenium og materialesaet til anvendelse ved fremgangsmaaden | |
EP0027908A3 (en) | 2-hydroxyalkyl-3,4,5,trihydroxy piperidines, processes for their preparation and their use as medicaments | |
ES8308553A1 (es) | "procedimiento de obtencion de nuevos derivados de piperazina". | |
ES8706715A1 (es) | Un procedimiento para preparar un derivado de uridina. | |
Whistler et al. | Crystalline xylobiose and xylotriose | |
JPS5629597A (en) | Alkyl glycoside of constituent unit disaccharide of acid mucopolysaccharide and oligosaccharide consisting of said disaccharide, and preparation thereof | |
DE3363641D1 (en) | Process for purifying secretin | |
Kloosterman et al. | The relative stability of allyl ether, allyloxycarbonyl ester and prop-2 enylidene acetal, protective groups toward Iridium, Rhodium and Palladium catalysts. | |
Rappoport et al. | Preparation of L-Arabinose-1-C14 1 | |
Sommer et al. | Paralytic Shellfish Poison. II. Purification by Chromatography1 | |
IT1168008B (it) | Imidazol-eteri ed ester, procedimenti per prepararli e composizioni farmaceutiche che li contengono | |
ES8506749A1 (es) | Procedimiento para la produccion de 1-n -(l-3-amino-2-hidroxipropionilo)- o 1-n-(l-4-amino-2-hidroxibutirilo)-2',3'-dideoxikanamicina a | |
FR2432499A1 (fr) | Procede de purification d'amines tertiaires | |
KR890012988A (ko) | 3,3-디아릴아크릴 산 아미드의 제법 | |
ATE32332T1 (de) | Verfahren zur herstellung von biarylverbindungen durch kupplung einer arylamin- und einer arenverbindung. | |
ATE34564T1 (de) | Verfahren zur herstellung von 2,4dihydroxybenzophenonen. | |
SU1049485A1 (ru) | Способ отделени алкалоидов полученных из растений родов @ , @ , @ и содержащих третичный атом азота,от их четвертичных солей и/или примесей | |
JPS56103197A (en) | Novel d-glucose derivative and antitumor agent containing the same as active constitutent | |
Hatanaka et al. | l-2-Amino-4-methylpimelic acid: A new amino acid from Lactarius species | |
CN85102990A (zh) | 高纯度烷基硫酸钠的合成 | |
ATE9477T1 (de) | Verfahren zur herstellung von 1,1'-diacetalen. | |
JPS54141794A (en) | Preparation of n-acylcephamycin c and its salt with organic base | |
JPS57116032A (en) | Preparation of alpha,beta-dehydro-alpha-amino acid ester |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
SUBM | Surrender of laid-open application requested |